These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3501190)

  • 61. Both class I and class II responsive T cell subsets can separately initiate lethal graft-versus-host disease in H-2-incompatible murine radiation chimeras.
    Carmody L; Atkinson K; Cooley M; Chapman G; Biggs J; McKenzie I
    Transplant Proc; 1987 Apr; 19(2):2876-8. PubMed ID: 3105125
    [No Abstract]   [Full Text] [Related]  

  • 62. Manipulation of T-cell content in transplanted human bone marrow: effect on GVH and GVL reactions.
    Truitt RL; Ash RC
    Prog Clin Biol Res; 1987; 244():409-21. PubMed ID: 3310003
    [No Abstract]   [Full Text] [Related]  

  • 63. Kinetics of prevention of graft-versus-host disease and bone marrow rejection by ultraviolet B modulation of bone marrow inoculum.
    Oluwole SF; Engelstad K; Hardy MA
    Transplant Proc; 1992 Dec; 24(6):2858-9. PubMed ID: 1465974
    [No Abstract]   [Full Text] [Related]  

  • 64. Effector cells of lethal graft-versus-host disease (GVHD) in nude mice.
    Uenaka A; Mieno M; Kuribayashi K; Shiku H; Nakayama E
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3031-2. PubMed ID: 2784924
    [No Abstract]   [Full Text] [Related]  

  • 65. T cell subsets controlling graft-v-host disease in mice.
    Sprent J; Korngold R
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):41-7. PubMed ID: 3501190
    [No Abstract]   [Full Text] [Related]  

  • 66. Function and specificity of T cell subsets in the mouse.
    Sprent J; Webb SR
    Adv Immunol; 1987; 41():39-133. PubMed ID: 2961215
    [No Abstract]   [Full Text] [Related]  

  • 67. Allorecognition and graft-versus-host disease.
    Theobald M
    Bone Marrow Transplant; 1995 Apr; 15(4):489-98. PubMed ID: 7655371
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 69. T-T cell interactions in cell-mediated immune responses to major histocompatibility complex antigens.
    Rich RR; Rich SS
    Crit Rev Immunol; 1983; 4(2):129-68. PubMed ID: 6221885
    [No Abstract]   [Full Text] [Related]  

  • 70. Monoclonal antibodies for the depletion of specific subpopulations of lymphocytes.
    Waldmann H; Cobbold S; Qin S; Benjamin R; Nash T; Welsh J; Tarnesby G
    Ciba Found Symp; 1987; 129():194-208. PubMed ID: 3315502
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Graft vs host reaction and graft vs host diseases].
    Sakagami K; Orita K
    Nihon Rinsho; 1985 Jan; 43(1):97-103. PubMed ID: 3886972
    [No Abstract]   [Full Text] [Related]  

  • 72. Lymphoid dendritic cells.
    Austyn JM
    Immunology; 1987 Oct; 62(2):161-70. PubMed ID: 3315976
    [No Abstract]   [Full Text] [Related]  

  • 73. Antigen presentation in graft-vs-host disease.
    Shlomchik WD
    Exp Hematol; 2003 Dec; 31(12):1187-97. PubMed ID: 14662324
    [No Abstract]   [Full Text] [Related]  

  • 74. T lymphocyte surface molecules: structure and function.
    Blann AD
    Med Lab Sci; 1987 Jul; 44(3):220-36. PubMed ID: 3323759
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.